Key facts
- Notable investors include Great Capital, Jiafa Investment, Supergravity Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Coastline Platinum Life Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Coastline Platinum Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Coastline Platinum Life Science
Manufacturer of advanced medical devices intended to enhance minimally invasive diagnostic and surgical procedures. The company offers ultra-fine caliber endoscopes, electronic imaging processors, and consumables, enabling healthcare providers and clinical practitioners to achieve greater precision, safety, and efficiency in patient care.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Website
- coastline.com.cn/
- Ownership
- Privately Held (backing)
Coastline Platinum Life Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Coastline Platinum Life Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Coastline Platinum Life Science in its N-PORT filings yet. We sweep new filings monthly.